Work

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

Year: 2006

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.21874

Authors: Paulo M. Hoff, Robert A. Wolff, Henry Xiong, Dennie Jones, Edward Lin, Cathy Eng, Ankhi Dutta, Karla R. Bogaard, James L. Abbruzzese

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas Medical Branch at Galveston

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2166676295

FWCI: 0.69

Cites: 36

Cited by: 10

Related to: 10